Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00461539 · ClinicalTrials.gov registry record · Phase 1

Reducing Health Risk Behavior and Improving Health in Adolescents With Depression

A Phase 1 study of Depression and Adolescent Health, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
217
Enrollment target
2
Study locations

NCT00461539 is a Phase 1 study of Depression and Adolescent Health that has completed, run by University of California, Los Angeles. The registered enrollment target is 217 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00461539, a Phase 1 study of Depression and Adolescent Health, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
217 participants
Enrollment target
2
Study locations

Study Summary

This study will determine the effectiveness of a health education intervention in reducing health risk behavior and improving health in adolescents with depression.

Interventions

  • OTHER Treatment as usual
  • BEHAVIORAL Behavioral health intervention

Study Locations (2)

California

  • University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior - Los Angeles
  • Kaiser Permanente Los Angeles Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 217 participants
Start Date 2007-10
Est. Completion 2012-01
Phase Phase 1

What the Registry Record Tells You About NCT00461539

The ClinicalTrials.gov registry entry for NCT00461539 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT00461539 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00461539 about?

NCT00461539 is a clinical study titled "Reducing Health Risk Behavior and Improving Health in Adolescents With Depression". This study will determine the effectiveness of a health education intervention in reducing health risk behavior and improving health in adolescents with depression.

What is the current status of trial NCT00461539?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 217 participants. The study started on 2007-10. Estimated completion is 2012-01.

What conditions does trial NCT00461539 study?

This clinical trial studies the following conditions: Depression, Adolescent Health.

What interventions are being tested in trial NCT00461539?

The interventions under investigation include: Treatment as usual (OTHER), Behavioral health intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00461539?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00461539 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.